Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Recent
Upcoming
Share :

ASCO GU 2024

Videos
News
ASCO GU 2024: Immunotherapy post-surgery improves overall survival for kidney cancer
ASCO GU 2024: Immunotherapy post-surgery improves overall survival for kidney cancer
ASCO GU 2024: Subcutaneous nivolumab as effective as IV for renal cell carcinoma with much faster treatment time
ASCO GU 2024: Subcutaneous nivolumab as effective as IV for renal cell carcinoma with much faster treatment time
ASCO GU 2024: Study shows positive results for patients with muscle-invasive urothelial carcinoma
ASCO GU 2024: Study shows positive results for patients with muscle-invasive urothelial carcinoma
ASCO GU 2024: Combination of cabozantinib and atezolizumab offers hope for patients with type of advanced prostate cancer with poor prognosis
ASCO GU 2024: Combination of cabozantinib and atezolizumab offers hope for patients with type of advanced prostate...

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation